Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

26 févr. 2018 08h00 HE | Source: Neos Therapeutics, Inc.

Neos Therapeutics Launches Adzenys ER™ (amphetamine) Extended-Release Oral Suspension in U.S. for the Treatment of ADHD in Patients 6 Years and Older

DALLAS and FORT WORTH, Texas, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing...
15 sept. 2017 16h39 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics Receives U.S. FDA Approval of Adzenys ER™ (amphetamine) Extended-Release Oral Suspension for the Treatment of ADHD in Patients 6 Years and Older

DALLAS and FORT WORTH, Texas, Sept. 15, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
30 août 2017 07h30 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics to Participate in Three September Conferences

DALLAS and FORT WORTH, Texas, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
26 juin 2017 16h01 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics Announces Proposed Offering of Common Stock

DALLAS and FORT WORTH, Texas, June 26, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
19 juin 2017 21h46 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT™ (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old

DALLAS and FORT WORTH, Texas, June 19, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
14 juin 2017 07h30 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at the JMP Securities 2017 Life Sciences Conference

DALLAS/FORT WORTH, Texas, June 14, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
30 mai 2017 07h30 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at Jefferies 2017 Global Healthcare Conference

DALLAS and FORT WORTH, Texas, May 30, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
16 mai 2017 07h30 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics to Present at 2017 UBS Global Healthcare Conference

DALLAS and FORT WORTH, Texas, May 16, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
09 mai 2017 07h00 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics Reports First Quarter 2017 Financial Results

DALLAS and FORT WORTH, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...
02 mai 2017 07h30 HE | Source: Neos Therapeutics, Inc

Neos Therapeutics to Host First Quarter 2017 Financial Results Conference Call on May 9, 2017

DALLAS and FORT WORTH, Texas, May 02, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative...

Page suivante